$CPRX at 'ascending' breakout $3.42 Nasdaq GM

$CPRX at 'ascending' breakout $3.42
Nasdaq GM
called 8/4/13 $1.61

100 % Buy

detailed opinion


Website


Shares Outstanding: 69.12M
Float: 49.99M
% Held by Insiders: 18.95%
% Held by Institutions: 20.20%
Shares Short (as of Jan 15, 2015) 4.36M
Short Ratio (as of Jan 15, 2015): 10.10
Short % of Float (as of Jan 15, 2015): 10.50%
Shares Short (prior month)3: 4.57M




10-Q 11/13/14
Summary

Recent trades



Headlines

Monday, January 19, 2015
Point72 Asset Management adds position in Catalyst PharmaceuticalMarket Realist (Mon, Jan 19)

Monday, January 12, 2015
CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 12)
Catalyst Pharmaceuticals Provides an Update of 2015 Goals for Its Product PortfolioGlobeNewswire (Mon, Jan 12)

Monday, January 5, 2015
CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Jan 5)
Catalyst Pharmaceuticals Appoints David D. Muth, Executive Vice President, Chief Commercial OfficerGlobeNewswire (Mon, Jan 5)

Thursday, December 18, 2014
The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Common Stock of Catalyst Pharmaceutical Partners, Inc. -- CPRXGlobeNewswire (Thu, Dec 18)

Wednesday, December 17, 2014
CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Wed, Dec 17)

Tuesday, December 16, 2014
Catalyst Pharmaceuticals Announces the Passing of Hubert E. Huckel, Co-Founder and DirectorGlobeNewswire (Tue, Dec 16)

Monday, December 1, 2014
Catalyst Pharmaceuticals to Present at the Piper Jaffray 26th Annual Healthcare ConferenceGlobeNewswire (Mon, Dec 1)

Monday, November 24, 2014
CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Mon, Nov 24)
Catalyst Pharmaceuticals Announces Notice of Allowance of U.S. Patent Application for the Reduction or Elimination of Visual Field Defects by Treating Patients With CPP-115GlobeNewswire (Mon, Nov 24)

Friday, November 21, 2014
CATALYST PHARMACEUTICAL PARTNERS, INC. FinancialsEDGAR Online Financials (Fri, Nov 21)

Saturday, November 15, 2014
10-Q for Catalyst Pharmaceutical Partners, Inc.Company Spotlight (Sat, Nov 15)

Friday, November 14, 2014
CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Fri, Nov 14)
Catalyst Pharmaceuticals Announces Third Quarter 2014 Financial ResultsGlobeNewswire (Fri, Nov 14)

Thursday, November 13, 2014
CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 13)

Wednesday, November 12, 2014
Will Catalyst Pharmaceuticals' (CPRX) Loss Narrow in Q3?Zacks (Wed, Nov 12)

Tuesday, November 4, 2014
CATALYST PHARMACEUTICAL PARTNERS, INC. Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online (Tue, Nov 4)
Catalyst Pharmaceuticals Announces Proposed Settlement of Pending Securities Class Action LawsuitGlobeNewswire (Tue, Nov 4)

Wednesday, October 8, 2014
Midday Gainers From October 8 - GT Advanced Technologies Inc, Unilife Corp And MoreBenzinga (Wed, Oct

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP